Commonly used drugs, such as beta-blockers, calcium-channel blockers, and digoxin, are also known to be poorly tolerated in TTR cardiac amyloidosis patients due to the restrictive filling physiology and heart rate dependence, favoring the adoption of the rhythm control strategy. The gene discussed is TTR; the disease is cardiac amyloidosis.